Dwarika-Pharmaceuticals Private Limited
About Dwarika-Pharmaceuticals Private Limited
Data last updated:
Dwarika-Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 25 January 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85100UP2022PTC158532.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prateek Karanwal and Abhishek Kumar Deshwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R – 7/D – 22 Ground Floor, Ghaziabad, Uttar Pradesh, India – 201002.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.78 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹12,583 (net margin 0.6%) and EBITDA of ₹21,608 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 230% over three years.
Company details
Contact details
Dwarika-Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressR – 7/D – 22 Ground Floor, Ghaziabad, Uttar Pradesh, India – 201002
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dwarika-Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Dwarika-Pharmaceuticals Private Limited, buy the company report.
Financials of Dwarika-Pharmaceuticals Private Limited
FY 2025 filings availableDwarika-Pharmaceuticals Private Limited reported revenue of ₹19.78 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 230% over three years, including 2% growth in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹21,608 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹12,583 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dwarika-Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dwarika-Pharmaceuticals Private Limited
Dwarika-Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Karanwal | Additional Director | 03 Nov 2025 | 0 Years 11 Months | Current |
| Abhishek Kumar Deshwal Also directs: Sri Ji Foods & Technology Private Limited, 4Amd Pharmaceuticals Private Limited, Andycox India Private Limited and 1 more | Additional Director | 03 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Dwarika-Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VS Medi Hub Private Limited | ₹19.94 Lakh (FY 2025) | -7.0% | Jaipur, Rajasthan, India | |||
| Zorbawellness and Therapy Private Limited | ₹19.92 Lakh (FY 2025) | Khalapur, Maharashtra, India | ||||
| Dwarika-Pharmaceuticals Private Limitedthis company | ₹19.78 Lakh (FY 2025) | ₹12,583 | 0.6% | 2.0% | Ghaziabad, Uttar Pradesh, India | |
| Hania Laboratories Private Limited | ₹19.67 Lakh (FY 2018) | 12.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Dwarika-Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dwarika-Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dwarika-Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dwarika-Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dwarika-Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Abhishek Kumar Deshwal was appointed as Additional Director on 03 Nov 2025.
Frequently asked questions
Dwarika-Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in human health activities, within the healthcare industry. It was incorporated on 25 January 2022 (4+ years old) and is registered under CIN U85100UP2022PTC158532.
Dwarika-Pharmaceuticals has 2 current directors:
- Prateek Karanwal - Additional Director
- Abhishek Kumar Deshwal - Additional Director
The latest financial statements of Dwarika-Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Dwarika-Pharmaceuticals is U85100UP2022PTC158532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dwarika-Pharmaceuticals was incorporated on 25 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Dwarika-Pharmaceuticals by revenue are VS Medi Hub Private Limited, Zorbawellness and Therapy Private Limited, Hania Laboratories Private Limited, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (other hospital and medical care activities).
Abhishek Kumar Deshwal was appointed as Additional Director on 03 Nov 2025. Prateek Karanwal was appointed as Additional Director on 03 Nov 2025. Pankaj Agarwal was appointed as Director on 25 Jan 2022. Dwarika-Pharmaceuticals has 4 board changes on record in total.
The registered office of Dwarika-Pharmaceuticals is at R – 7D – 22 Ground Floor, Ghaziabad, Uttar Pradesh, India – 201002.
Dwarika-Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
Dwarika-Pharmaceuticals can be reached at its registered office: R – 7D – 22 Ground Floor, Ghaziabad, Uttar Pradesh, India – 201002.
Dwarika-Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.